BP vs EQNR

BP's Advanced Deterministic Scorecard shows a Piotroski F-Score of 6/9, indicating stable financial health, but the absence of an Altman Z-Score limits distress risk assessment. The stock trades at a significant premium to its Graham Number ($7.35) and even the growth-based intrinsic value ($18.88), currently priced at $36.53, driven by high forward earnings expectations. While profitability metrics and dividend yield are attractive, elevated valuation multiples, inconsistent earnings surprises, and a dangerously high payout ratio of 315% raise sustainability concerns. Analysts recommend a 'buy' with a target of $38.73, supported by strong insider sentiment, though no insider transactions have occurred recently.

Equinor exhibits a stable financial foundation with a Piotroski F-Score of 6/9, but it is currently trading at a severe premium to its deterministic value. The current price of $37.94 is more than double the Graham Number ($18.78) and nearly triple the growth-based intrinsic value ($13.58). This valuation gap is compounded by sharply negative growth metrics, including a 27.3% YoY decline in earnings and a 0/100 bearish technical trend. While the balance sheet is healthier than the sector average, the combination of valuation overshoot and deteriorating fundamentals suggests significant downside risk.